Earnest Partners LLC filed Amendment No. 3 to its Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,572,707 shares of CTS Corp common stock as of September 30, 2026.
Michael Rapino, President and CEO of Live Nation Entertainment, Inc. (NYSE:LYV), filed a Form 4 on November 13, 2026, disclosing an option exercise and three open-market stock sales all executed on November 12, 2026.
The Bank of Nova Scotia filed a free writing prospectus on November 12, 2026, disclosing the summary terms of Trigger Performance Leveraged Upside Securities linked to the S&P 500 Index, with a maturity date of December 3, 2032, under Registration Statement No. 333-298611.
SDR Drone, Inc. filed a Form 8-K on November 13, 2026, disclosing that it entered into an engagement letter with Dawson James Securities, Inc. on November 10, 2026, to act as lead placement agent for a proposed bridge financing and/or private placement targeting gross …
Director Zena Srivatsa of MARZETTI CO filed a Form 4 on November 13, 2026, reporting changes in beneficial ownership of common stock and restricted stock units dated November 11, 2026.
John B. Gerlach Jr., Executive Chairman and Director of Marzetti Co (NASDAQ:MZTI), filed a Form 4 with the SEC, signed on November 13, 2026, reporting transactions dated November 11, 2026, involving both common stock and restricted stock units.
Earnest Partners LLC filed Amendment No. 4 to its Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,956,035 shares of Albany International Corp's Class A Common Stock as of September 30, 2026.
NetSol Technologies, Inc. filed a Form 8-K on November 13, 2026, disclosing that the company issued a press release on November 12, 2026 announcing results of operations and financial condition for the quarter ended September 30, 2026.
Director Elliot K. Fullen filed a Form 4 with the SEC on November 13, 2026, reporting changes in beneficial ownership of Marzetti Co (NASDAQ:MZTI) common stock and restricted stock units dated November 11, 2026.
Aaron Bloomer, Chief Financial Officer of ResMed Inc., filed a Form 4 on November 13, 2026, reporting a disposition of 1,095.137 shares of ResMed common stock on November 11, 2026, for tax withholding purposes related to a vesting restricted stock unit award.